Category: Information

Essential cancer screening and diagnosis services must be included in UHC schemes to reduce mortality

The earlier a cancer is detected, the easier it is to treat successfully, often with fewer side effects, and at a lower cost. In many high-income regions, such as Europe and the United States, survival rates for cancer have risen in past decades, in part thanks to routine screening that detects cancers at an early stage. It’s especially true for common cancers like cervical, breast, colorectal, and prostate, where routine screening offers a clear test and methodology for early detection.

Investing in routine screening programmes for asymptomatic cancers as well as the early detection of symptomatic cancers and diagnostic and referral services is, therefore, a cost-efficient approach to mitigate the public health costs of cancer. These are estimated to reach USD 458 billion globally by 2030, and cut the projected global economic cost of cancers, estimated at USD 25.2 trillion for the period 2020-2050.

Such investments in services must be accompanied by clear communication about the necessity and benefits of such measures. It is also critical that the general public have access to reliable information on possible early signs of certain cancers (notably, breast, cervical, lung, prostate, ovarian and testicular) and primary healthcare staff must be equipped to spot signs of cancer – with rapid referral options for screening and then treatment.

Unfortunately, many people around the world still lack access to these essential services. In low- and middle-income countries in particular, cancer prevention, diagnosis and care remain a luxury that is out of reach for many.

A significant number of people, particularly those from low-income communities, face barriers that prevent them from accessing necessary health services, such as the distance to healthcare facilities and costs of healthcare – with the risk of financial toxicity if they must be paid for out of pocket.

A weak health system and an absence of knowledgeable healthcare providers can also stand in the way of timely cancer detection and diagnosis.

To close these gaps, routine screening, cancer diagnosis and referral services must be included in health insurance benefits packages.

UHC cannot be achieved unless everyone has access to affordable cancer care. At the same time, without the benefits offered by UHC, access to potentially life-saving screenings remains limited. This means someone may die of a cancer that could have been detected and treated at an earlier stage, but either an early detection programme was not available or that person could not access it, for financial or other reasons. A cost-efficient national cancer control plan with essential services – including routine screening and diagnosis – covered by national health insurance schemes available to everyone – can break down these barriers to accessibility, availability and affordability.

Indeed, often cancer treatment by national health insurance schemes but not screening. Issues of stigma that surround many cancer tests (for instance, those that concern sexual organs) therefore compound concerns about cost or fears of a diagnosis (e.g. cancer may be considered a death sentence, so why get tested?) to prevent high numbers of people getting a timely diagnosis, resulting in many patients presenting with late-stage cancers.

At the second High-level Meeting on Universal Health Coverage taking place on 21 September 2023, Governments are expected to adopt a set of new commitments to accelerate UHC implementation. This meeting will provide an opportunity for UICC to advocate for including comprehensive cancer prevention and control measures in UHC benefits packages.

In preparation for this pivotal meeting, UICC reached out to its members to learn about their concerns and inform its advocacy strategy in the lead-up to the UN HLM on UHC.

UICC is also organising a series of Virtual Dialogues intended to facilitate discussions around UHC and its impact on cancer control. The first dialogue organised in early May looked at UHC and prevention. A second Virtual Dialogue on UHC and early detection will take place on 20 July, and look at examples of successful advocacy to include screening and early detection in UHC benefit packages (for instance, mammography reimbursement in Algeria) and the use of legislation to support screening and early detection programmes and referral to treatment.

Read more :

https://www.linkedin.com/pulse/essential-cancer-screening-diagnosis-services-must-included-uhc-schemes%3FtrackingId=yU3y0j6Af4hHzyucBwUSyw%253D%253D/?trackingId=yU3y0j6Af4hHzyucBwUSyw%3D%3D

 

Empowering patients through medical technologies for a healthier future

By constantly investing in existing and future technologies, the medical technology sector contributes to a healthier Europe. The 2023 MedTech Forum looked at some key trends in legislation and business and the role that EU policymakers can play to bring medical innovations to patients in a timely manner.

Europe takes great pride in its robust social security systems and the fundamental principles of equitable healthcare access. Data indicates however that significant efforts are still required to ensure that all patients across the continent enjoy top-tier quality care and unfettered access to medical services and technologies.

Medical technologies empower early diagnoses, timely interventions, and remarkable outcomes. Medical technologies mend, revive, and improve body functions, while telemedicine and connected devices bring patient monitoring to new frontiers. Innovations speed up recovery, safeguard well-being, and equip healthcare workers with vital insights for optimal decisions and fewer complications. By relieving strain on healthcare systems, fostering social and economic vitality, averting complications, and advancing efficiency through cutting-edge data and machine learning, medical technologies are high-tech, high-value game-changers in healthcare. Diagnostic technologies also act as a first line of defence against disease outbreaks and help support their management.

Because of its innovation power, and its positive impact on patients, healthcare professionals, and health systems, the medical technology sector has developed into a key industry with an important economic and societal impact in Europe.

European leadership for the benefit of patients 

Europe’s 34,000 medical technology companies invest heavily in improving existing and innovating breakthrough technologies for the benefit of patients. These companies, 95% of which are SMEs, drive economic growth, provide employment in Europe, and boost EU exports. In doing so, the sector adheres to strict regulatory standards that ensure safe devices which live up to their performance claims. Patient health and well-being in mind, no other region in the world sets such high standards to guarantee that medical technologies are safe for patients and healthcare professionals to use.

Despite Europe’s fundamental strengths in health and medical solutions, there are growing indicationsthat new and existing products will struggle to reach European patients and health systems in a timely manner: 17% of today’s in vitro diagnostics are expected to be discontinued in Europe, particularly among SMEs and approximately 50% of medical device manufacturers are deprioritising the EU market (or will do so) as the geography of choice for first regulatory clearance of their new devices.

MedTech Europe, the leading European medical technology trade association, believes that there are persistent, system-level issues within the European regulations for medical technologies which lead to unpredictability and delays, dampen innovation, and undermine confidence in the long-term viability of the regulatory framework.

To remain a global leader in medical technologies, the EU must deliver a more patient-centred and innovation-friendly regulatory framework that addresses the system-level challenges of today while preparing for the opportunities of tomorrow.

Getting through the maze 

Beyond the medical technology industry’s sector-specific developments, fundamental changes have been brought about in the last decade by the mega trends of digitalisation and sustainability. Such trends contribute to a revolution in the way innovation in medical technologies is happening, driving the need for a more forward-looking regulatory mentality to allow innovation to thrive.

Legislative activity of the EU in this area has been, rightly, immense – and much more needs to be done to ensure that all the rules-in-development which will impact medical technologies will actually work together to deliver products to patients. The EU’s Digital Strategy, driving regulation on artificial intelligence, cybersecurity, and data, including the European Health Data Space and the European Green Deal will legislate tectonic changes, including in the area of product design, are coming with a substantial set of new or updated requirements for medical technologies.

Against this background, substantial legislations are also being revised, such as the ones on Product Liability and Corporate Sustainability Due Diligence. It is paramount to include principles that ensure patients across the EU can benefit from a high level of protection and businesses are provided with legal certainty.

These new rules will significantly impact the way and speed in which technologies can be brought to market and accessed by those who need them. Getting medical technology innovations to European patients and healthcare systems in fact can often feel like navigating a complex and ever-shifting maze.

As a result, whether for R&D investment, clinical research, manufacturing or new product launches, Europe slowly losing ground to other geographies on innovation, because the maze seems to be getting harder to navigate. The EU thus has a big task ahead to further its efforts towards driving harmonisation and creating an environment of legal certainty for businesses.

The slowly approaching end of the EU legislative cycle is a unique opportunity to reflect on what has been achieved and what is still to be done. It is not a time to rush to the finish line but to stay level-headed and look for effective solutions to ensure medical technologies reach patients on time. We need to solve existing challenges in a comprehensive, sustainable manner, setting the tone for a future environment that will allow patients to continue benefiting from first-line, quality medical technologies and more equitable access to healthcare, and health systems to build the long-term resilience they need. The medical technology industry in Europe stands ready to contribute and collaborate to make this a reality.

This article was produced in partnership with Medtech Europe. MedTech Europe is the European trade association for the medical technology industry including diagnostics, medical devices and digital health.

https://www.theparliamentmagazine.eu/news/article/empowering-patients-through-medical-technologies-for-a-healthier-future

A post-emergency COVID-19 vaccine strategy: WHO’s end of emergency declaration spells out hope but challenges remain

The declaration of the end to COVID-19 as a public emergency is a symbolic signpost, but COVID-19 remains a threat and vaccination can play a key role in addressing it.

The declaration of the end to COVID-19 as a public health emergency is a symbolic signpost of the transition from an emergency to a more sustainable mode of preparedness and reaction. COVID-19 remains a threat though, and vaccination can play a key role in addressing it.

Thirty-eight months into the pandemic, and COVID-19 claims a life every three minutes globally. This leaves no room for complacency.

Instead, we need, to remain vigilant, have a coherent approach on vaccination and continue reducing COVID-19 hospitalisations, severe disease, as well as protecting our healthcare systems.

In this regard, Member States should strive for a better coordination among their national vaccination strategies in order to avoid major differences, with the EU having a stronger role through further harmonisation of some aspects of the vaccine administration in the Member States.

At the same time, while predictable pattern of COVID-19 seasonality has yet to be established, the impact of the disease has been much higher during the period corresponding to the traditional influenza season. Therefore, where possible, COVID-19 and influenza vaccination campaigns need to be combined.

Second, we need to reflect on the use of joint procurement as part of the EU’s vaccine strategy.

The strategy has been one of the milestones of the EU’s response to the pandemic. It demonstrated the unity of the EU as a whole, facilitated access to a broad and diversified portfolio of safe and affordable vaccines, and saved the lives of more than a million Europeans since the end of 2020.

Capitalising on this success, we need to go one-step further and, seriously, consider extending it to treatments of very rare types of cancer, especially paediatrics, as well as some rare diseases.

Nevertheless, increasing public confidence in vaccination is a key prerequisite to reach these strategies’ objectives.

As EPP Coordinator at the COVI Committee, I find the major disparities in vaccination coverage between and within Member States as well as the resurgence of vaccine-preventable diseases, such as measles, quite concerning. In order to address these, we have to continue tackling misinformation and disinformation, and reduce vaccination hesitancy through science-based communication on the benefits of vaccination.

Last, we should not forget that these challenges are essentially global. The EU played a decisive role in the global response to the COVID-19, by donating hundreds of millions of doses, and billions of aid to assist developing countries.

Building on that, the EU has to continue playing its role in providing support, improving access to vaccines for LMICs, as well as, boost global health research to develop the technologies and countermeasures, which are necessary to improve health.

By Stelios Kympouropoulos

Stelios Kympouropoulos (EL, EPP) is a member of Parliament’s EMPL and PETI Committees, the SANT Subcommittee and the COVI Special Commmittee.

Digital and digital non-clinical solutions

➡️What will be the digital and digital non-clinical solutions for people with cancer in the future 🧐
This post aims to consider some possible digital solutions to bring medical resources and information to patients in the future.

➡️📱Mobile Apps: Mobile cancer apps can play a crucial role in patient education, symptom management and treatment monitoring.
These apps could provide information about cancer, medications, side effects, proper diets, as well as reminders for medications and medical appointments.

➡️⌨️Connected objects and wearables:
Wearable devices such as smart watches, bracelets and monitoring sensors could be used to monitor the vital signs of cancer patients in real time.

➡️Artificial Intelligence
(Al) and Data
Analytics: Al can be used to analyze large amounts of medical data and help identify patterns, correlations and predictions. This could contribute to a better understanding of risk factors,
treatment responses and patient
outcomes.

➡️Virtual Reality (VR):
Virtual reality can be used to help cancer
patients manage pain, anxiety and stress. Calming and interactive virtual environments can be created to distract patients during medical treatments or to help them relax during difficult times

For more just read: E-Health4Cancer : Sharing good practices in the use of nonclinical e-health solutions for cancer patients and their caregivers in Europe. Non-profit Organizations

https://www.linkedin.com/company/ehealth4cancer/

WHO/Europe explores collaborations to improve quality of health information online

The WHO Office on Quality of Care and Patient Safety in Athens recently joined forces with YouTube Health to host a workshop in Berlin to enhance the quality of health information online and support Member States’ efforts in this area. This collaborative endeavour lays the groundwork to promote health literacy and make high-quality health information universally accessible.

“We are very much looking forward to working together for a world where people can access the health information they need online without having to guess its accuracy,” noted Dr Natasha Azzopardi-Muscat, Director of WHO/Europe’s Division of Country Health Policies and Systems, at the workshop.

The role of digital platforms in health

The COVID-19 pandemic brought into the spotlight the prominent role of digital platforms in disseminating health-related information and the importance of reliable information, while also exposing the potential perils of misinformation and disinformation. Data indicates that, in the WHO European Region, a large share of consultations now take place online, as people’s initial approach is to search for symptoms and medical advice online. Health-related searches make up 7% of daily online searches, with approximately 4 billion results related to COVID-19.

In 2021, YouTube had over 110 billion views of health condition videos globally and is working on raising high-quality health content to make it easier for people to identify credible information that can help answer their questions. Commenting on the platform’s impact in the online space, Dr Nira Goren, Clinical Lead at YouTube Health, said, “People use platforms like YouTube to seek answers to questions, such as how do I live with breast cancer or how do I take care of myself.” An increasing number of individuals are also turning to online platforms to share personal stories, alleviate acute distress, and build a community to help decrease feelings of isolation.

However, online health information that is inaccurate or misleading can pose a significant risk to one’s health. A recent WHO review showed that infodemics and misinformation negatively affect people’s health behaviours. The distorted understanding of health hazards, such as smoking, alcohol intake, unhealthy eating habits, or physical inactivity, can result in various life-altering and potentially fatal noncommunicable diseases (NCDs), such as cancer or diabetes.

Empowering health through high-quality health information online

High-quality health information can empower individuals to take control of their health, make informed decisions about their treatment options, and improve their overall well-being and quality of life. With more and more people relying on the internet for medical advice, it is essential that the information available is reliable, accurate, easy to understand, and up-to-date. Collaboration with health care stakeholders in Member States across the Region is needed to ensure this. It also requires fostering inclusive partnerships that bring together patients, health care professionals, ministries, nongovernmental organizations, and major social media platforms.

“Social media platforms are crucial tools to improve and disseminate high-quality health information online and we should work on that together, involving everyone in this process. Our primary focus should be to actively listen to community concerns, promote understanding of risk and health expert advice, engage and empower communities to take positive action, and support health professionals and

Moreover, fostering trust in authoritative online health information sources at the population level entails working with academia and other partners to create further scientific evidence on the impact of misinformation on quality of care, acting as a lighthouse in consolidating the creation of scientific evidence.

“Empowering communities with education is essential to helping people live healthier lives. YouTube Health is delighted to interact with WHO and authoritative health sources across Europe to increase access to evidence-based, equitable and engaging health information,” noted Dr Garth Graham, Director and Global Head, Healthcare and Public Health, YouTube.

Πηγή: who.int

Depression Is Often Overlooked in Cancer Patients

When Carly Flumer was a teenager, she was diagnosed with anxiety and depression. She saw a psychiatrist and a therapist regularly, and got medication and counseling. She managed her mental health well for over a decade. But in January 2017, she was diagnosed with an aggressive form of thyroid cancer that had spread to her lymph nodes by the time it was diagnosed.

That’s when things got complicated again.

Flumer, then 27, underwent surgery to remove her thyroid. She also received intensive radiation. To all observers, she got a clean bill of health — at least with regard to her cancer. But, she says, her mental health had suffered.

“People absolutely do not understand the panic a cancer diagnosis can cause,” Flumer says. “My depression and anxiety got worse when I got diagnosed. I also have had more suicidal thoughts because of the cancer,” she says. “The side effects of treatment are real. So is the stress of waiting to see if the cancer comes back again.”

The Economics of Health for All and the Transformative Power of the Arts

In the first-ever report of its kind, the WHO Council on the Economics of Health for All has outlined a bold new path to reorient economies to deliver what matters – health for all.

The Council has put forward a bold new narrative grounded in new economic wisdom to reorient economies to deliver health for all across four interrelated themes:

  1. Value – valuing and measuring what matters through new economic metrics;
  2. Finance – how to finance health for all as a long-term investment, not a short-term cost;
  3. Innovation – how to advance health innovation for the common good;
  4. Capacity – how to strengthen dynamic public sector capacity to achieve health for all.

Meet the new WHO Goodwill Ambassadors for Arts and Health

The appointments of Fleming and Yende underscore the profound link between arts and health. Engagement in creative activities, such as music, art, and dance, positively impacts physical, mental health, social well-being, and overall quality of life.

Through their roles as Goodwill Ambassadors, Fleming and Yende will promote the integration of arts into healthcare systems, advocate for access to creative arts therapies, and champion the importance of artistic expression in improving health outcomes globally.

Health for All Film Festival

A shortlist of 93 films has been selected for the 4th Health for All Film Festival out of more than 780 entries received.

Watch the shortlisted films here. Winners will be announced on 6 June.

Key highlights from the Seventy-sixth World Health Assembly

As the world faces ongoing health and humanitarian emergencies, the Seventy-sixth World Health Assembly focuses on driving forward health for all. This year’s session of the World Health Assembly determines the immediate and longer-term future of WHO, starting with the program budget for the next two years, key decisions about the sustainable financing of the Organization and changes put in place to improve WHO’s processes and accountability. Delegates also deliberate about the critical role that WHO has in the Global Health Emergency Architecture.
Read more :

World Health Organization

The importance of social support for cancer patients on the path to treatment.

A cancer diagnosis is a life-changing event for individuals to the point that it makes them feel anxious along with fear and a diminished sense of control over life.

Coping with the physical, emotional and psychological challenges of cancer can be incredibly difficult, which is why social support plays a key role in the journey to treatment for cancer patients. Social support encompasses a wide range of resources, including emotional, informational, tangible and practical support, and can come from a variety of sources, including family, friends, healthcare providers, support groups and communities.

Emotional support is the fundamental component of social support for cancer patients, as coping with cancer can cause immense emotional distress, such as fear, grief, anger and anxiety.

Where do we want to go? Can knowledge from inclusion with one another be the solution to alleviate psychological distress?

Having a support system can provide cancer patients with a safe space to express their feelings, be heard and receive understanding through empathy. Emotional support can help relieve the psychological burden of cancer, reduce stress and improve mental health outcomes. Studies have shown that cancer patients who receive emotional support from loved ones or participate in support groups experience lower levels of anxiety and depression and have improved quality of life.

Valid information: knowing where we are going.

Informational support is another critical aspect of social support for cancer patients. Understanding the complexities of cancer, treatment options and the healthcare system in general can be an important knowledge tool in order for the patient to know where they are going and what they need to “build” psychologically to cope with the difficult stage of treatment.

Also, access to accurate and reliable information can empower cancer patients to make informed decisions about their treatment plans, manage side effects and engage in self-care practices. Healthcare providers, cancer support organisations and authoritative online resources can provide valuable informational support to patients and their caregivers, enabling them to better cope with the challenges of cancer.

Lean on me.

Social support can take many different forms. One of these is tangible support, which includes help with practical tasks, making it essential for cancer patients. Cancer treatments can be physically demanding and exhausting. Support such as transport to appointments, meal preparation and household chores can significantly ease the burden on patients and their carers, allowing them to focus on their treatment and recovery. Friends, family and community organizations can provide essential support that helps patients manage their daily activities and maintain a sense of normalcy during a difficult time.

I change you the moment you change me.

Social support also plays a critical role in improving treatment outcomes for cancer patients. Research has shown that patients with strong social support systems tend to have better adherence and commitment to treatment plans, better physical recovery and a reduced risk of complications. Social support can also have a positive impact on cancer patients’ immune systems, reduce inflammation and enhance overall physiological function, contributing to better treatment outcomes. In addition, social support can provide cancer patients with a sense of hope, motivation and purpose, which can enhance resilience and coping skills, ultimately improving their ability to manage the challenges of cancer.

We are together and we are moving forward.

In addition to the emotional, informational, tangible and treatment-related benefits, social support can also create a sense of community for cancer patients. Joining support groups, connecting with others who have similar experiences and participating in cancer-related events can provide a sense of belonging and reduce feelings of isolation. Social support can also enhance a sense of inclusion and normalisation as patients realise that they are not alone in their journey and can draw strength from others who have successfully gone through similar challenges (“I went through this stage too and now I am here for you”). Building social connections and meaningful relationships can provide cancer patients with a sense of purpose, social engagement and improved overall wellbeing.

It is important to note that social support is not a one-size-fits-all approach and may vary according to individual preferences, cultural norms and personal circumstances (closed and open social). Some patients may prefer more private forms of support, while others may find comfort in larger support groups. The type and amount of social support required may also change during the cancer course and it is important that patients’ choices and boundaries are respected.

In closing, I would say that sometimes, if possible, it is good to let go, not to be afraid of what we have to say (let us judge and be judged under the umbrella of a healthy process) and let the environment decide what stays and goes from a discussion about the concern raised in each case. This leads us to the choice of the most appropriate behaviour.

Inclusion brings feedback and then eventual revision.

**Please note that it is always recommended to consult multiple sources and to consult health professionals for individualized medical advice.**

For useful information – resources:

Women Less Satisfied With Cancer Care

WHEN STEPHANIE RIVERA’S DOCTOR DISCOVERED THYROID NODULES during a routine exam in 2019, she began getting yearly thyroid ultrasound monitoring. She was told that 95% of the time these nodules are benign, but that she should watch for symptoms. “My doctor said if anything changes—if my voice changes or if I have trouble swallowing—I should come in sooner than my annual check-up,” says Rivera, 54, CEO of the Lazarex Cancer Foundation, which focuses on breaking barriers to health care for marginalized communities.

In April 2022, when Rivera began to experience unusual hoarseness five months before her scheduled annual thyroid ultrasound, she called her doctor as directed. But instead of getting an expedited appointment, “I was told, ‘Everything is fine. Just come back in August when you’re supposed to,’” Rivera says. When her hoarseness continued, Rivera called her doctor’s office again, and the medical staff relayed the same message: “Just come back in August.”

After that August check-up, however, Rivera was diagnosed with thyroid cancer that had spread to her lymph nodes. Rivera felt validated but remorseful. “Statistically, I wasn’t supposed to have thyroid cancer that has metastasized, but I knew my body. I should have called a third time and said, ‘This hoarseness is different. I need to come in now just to make sure everything is OK,’” she says.

Rivera is far from alone in having her cancer symptoms dismissed. According to a recent American Cancer Society Cancer Action Network (ACS CAN) survey involving 1,236 patients with cancer and survivors who have been diagnosed or treated within the past seven years, women were twice as likely as men (6% vs. 3%) to have reported symptoms five or more times before getting a diagnosis. For patients diagnosed after experiencing symptoms (as opposed to those diagnosed after screening), women were less likely than men to report that their symptoms were taken very seriously (31% vs. 21%) or taken seriously “at all” (8% vs. 1%).

“These small survey numbers echo a bigger trend women may be experiencing throughout their cancer journey: that physicians are not listening to them,” says Sarah Long, ACS CAN project manager for survey administration and analysis. “The fact that women, in particular, were going to physicians repeatedly and saying repeatedly, ‘I have these symptoms,’ and those symptoms were not taken seriously is an issue.”

Advertisement

Having initial cancer symptoms dismissed may especially be a problem for younger, healthy-looking women who don’t fit the profile of what doctors believe to be a typical cancer patient, Long says. According to ACS CAN survey respondents, physicians are apt to chalk up younger patients’ symptoms, such as feeling tired, to having a stressful job or a too-busy life, when, in fact, after pushing for follow-up appointments and additional testing, many of these women are eventually diagnosed with cancer.

“Women are having to say, ‘No, this isn’t normal for me’ over and over again,” says Kirsten Sloan, managing director of public policy at ACS CAN. “What we’re concerned about are those women who don’t say it over again, who just accept what their doctor says, rather than pushing for more testing. If it is cancer, they later find out it could have been diagnosed and treated sooner, with potentially a more favorable prognosis.”

Who is to blame? “It’s not the fault of the doctor. It’s the high-pressure system doctors find themselves in. The models of care are not as patient centered as they need to be,” Sloan says. “If you’ve only got a 15-minute visit, you don’t have much time to figure out which symptoms don’t make sense for the patient’s life.”

If You Feel Something, Say Something Again and Again

Still, there is no time to wait for the system to change, if it ever does. “As health care consumers, we need to educate ourselves about the symptoms to look for, make sure we’re doing our routine screenings so things are caught early, and be really good advocates for ourselves,” says Sloan. “We also need to find a doctor who listens in the way we need to be listened to.”

Advertisement

Rivera, who has worked directly with doctors on various levels at major health care networks for more than 30 years, has learned a lot about herself from her experience being diagnosed with thyroid cancer. “If this can happen to me, it can happen to anyone,” she says. “I trusted my doctor. And, apparently, I trusted him very much. What I didn’t trust was myself enough to say: ‘I know my body, and something is different. I need to be seen now for peace of mind.’”

Rivera says pushing back is not in her comfort zone. Insisting on being heard by your doctor or your clinical care team can feel like talking back to the teacher or your boss. Still, when something doesn’t feel right, your life can depend on it. “The lesson I learned is that my voice about my body is a top priority,” Rivera says.

Women Less Satisfied With Cancer Care

World Health Organization releases new road map for breast cancer

The World Health Organization (WHO) has released a new road map on breast cancer, with a target of saving 2.5 millions lives from the disease by 2040.

Currently, there are more than 2.3 million cases of breast cancer that occur each year, making it the most common cancer among adults.

However, survival from breast cancer is widely inequitable between and within countries, WHO reports, with nearly 80% of deaths from breast and cervical cancer occurring in low- and middle-income countries.

“Countries with weaker health systems are least able to manage the increasing burden of breast cancer,” said Dr Tedros Adhanom Ghebreyesus, director-general of WHO.

“It places a tremendous strain on individuals, families, communities, health systems and economies, so it must be a priority for ministries of health and governments everywhere,” he added.

WHO’s new global breast cancer framework recommends countries implement ‘three pillars of health promotion’ for early detection, timely diagnosis and comprehensive management of breast cancer to reach the targets.

This includes investing in breast cancer early-detection programmes so that at least 60% of the patients are diagnosed and treated at an early stage in their disease.

The other pillars include diagnosing breast cancer within 60 days of initial presentation and ensuring treatment starts within three months of first presentation, as well as ensuring at least 80% of patients complete their recommended treatment.

Dr Bente Mikkelsen, WHO director for noncommunicable disease, said: “Countries need to ensure that this framework engages and integrates into primary healthcare. This effort would not only support health promotion, but also empower women to seek and receive health care throughout the life cycle.”

“With effective and sustainable primary healthcare, we can really see a pathway to universal health coverage.”

The new framework which, according to WHO, could prevent millions of otherwise avoidable cancer deaths in women, follows the World Health Assembly passing a resolution in 2017 pushing for the same actions for control.

Since 2018, WHO has developed integrated initiatives in women’s and children’s cancers, also calling for the elimination of cervical cancer and a doubling of childhood cancer survival rates.

Taken together, experts say these initiatives can ‘revert the generational harm’ from cancers and save more than a million lives in the next ten years.

Πηγή: pmlive.com